The Maharashtra government has decided to bear the cost of the intravenous immunoglobulin (IVIG), a blood product made up of antibodies and other care components involved in treating Covid-linked multisystem inflammatory syndrome in children (MIS-C), at designated hospitals and medical colleges across the state.
The decision has been taken in view of the rising cases of post-Covid MIS-C across the state. Around 500 children are likely to be currently undergoing treatment for post-Covid MIS-C in Maharashtra.
The state-sponsored Health scheme, Mahatma Phule Jana Arogya Yojana (MPJAY), allowed IVIG expenses up to Rs1 lakh to a 5-year-old patient, son of a Bhavani Peth autorickshaw driver. The child is undergoing treatment at Bharati hospital.